Share This Page
Litigation Details for Alere Medical, Inc. v. Health Hero Network, Inc. (N.D. Ill. 2007)
✉ Email this page to a colleague
Alere Medical, Inc. v. Health Hero Network, Inc. (N.D. Ill. 2007)
| Docket | ⤷ Start Trial | Date Filed | 2007-12-18 |
| Court | District Court, N.D. Illinois | Date Terminated | 2008-03-06 |
| Cause | Assigned To | Amy J. St. Eve | |
| Jury Demand | Referred To | ||
| Patents | 8,975,243 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Alere Medical, Inc. v. Health Hero Network, Inc.
Details for Alere Medical, Inc. v. Health Hero Network, Inc. (N.D. Ill. 2007)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2007-12-18 | External link to document | |||
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
Litigation summary and analysis for: Alere Medical, Inc. v. Health Hero Network, Inc. (N.D. Ill. 2007)
Alere Medical v. Health Hero Network (1:07-cv-07145): Litigation Summary, Claims in Dispute, and Key IP Exposure
Alere Medical, Inc. v. Health Hero Network, Inc. (D.N.J., 1:07-cv-07145) is a federal IP dispute in which Alere asserted infringement claims against Health Hero Network. The docket reflects active litigation over pleadings and motions, with downstream settlement and/or case disposition reflected by docket events after initial filings. Publicly accessible docket-level information is not sufficient here to produce a complete, accurate claim-by-claim analysis (asserted patents, asserted claim scope, technology at issue, infringement theory, validity/affirmative defenses, and dispositive rulings).
What patents were asserted in Alere Medical, Inc. v. Health Hero Network, Inc. (1:07-cv-07145)?
Featured answer: The patents asserted in 1:07-cv-07145 are not stated in the information available in this record, so the specific patent numbers and claim sets cannot be listed accurately.
Which IP rights were at issue: patent, trademark, copyright, trade secret?
Featured answer: The case caption and docket identifier confirm a civil action, but the IP categories (patent vs trademark vs other) and the exact asserted rights are not provided in the available material.
If patents: which families and key expiration dates?
Featured answer: No patent identifiers are available, so no expiration or family scope can be mapped.
If trademarks: what marks and classes were asserted?
Featured answer: No trademark identifiers are available, so no Likelihood-of-Confusion factor analysis can be grounded.
If trade secrets: what disclosures or misappropriation facts were pleaded?
Featured answer: No trade secret assertions or pleadings are present in the available material.
What did Alere Medical allege, and what infringement theories did it use in 1:07-cv-07145?
Featured answer: The allegations and infringement theories cannot be reproduced accurately without the operative complaint or claim chart details, which are not contained in the information available here.
Method-of-use vs product claims
Featured answer: Not determinable from the provided record.
Direct infringement, inducement, or contributory infringement
Featured answer: Not determinable from the provided record.
Willful infringement and damages model
Featured answer: Not determinable from the provided record.
Validity challenges Alere anticipated
Featured answer: Not determinable from the provided record.
What defenses did Health Hero Network raise in Alere Medical v. Health Hero Network?
Featured answer: Defense content (non-infringement positions, invalidity grounds, estoppel, waiver, licensing, or lack of standing) is not available in the provided material, so the defense architecture cannot be summarized without introducing inaccuracies.
Non-infringement
Featured answer: Not determinable.
Invalidity and unenforceability
Featured answer: Not determinable.
Procedural defenses
Featured answer: Not determinable.
What is the procedural timeline for 1:07-cv-07145 (motions, hearings, amendments, and final disposition)?
Featured answer: The procedural timeline cannot be fully enumerated because the specific docket events (dates and order titles) are not included in the information available here.
Early stages: filing and pleadings
Featured answer: Filing is confirmed by the case identifier, but the sequence of complaint, answer, amended pleadings, and scheduling orders is not available here.
Markman, claim construction, or technical hearings
Featured answer: Not determinable from the provided record.
Summary judgment and dispositive motions
Featured answer: Not determinable from the provided record.
Trial or settlement posture
Featured answer: Not determinable from the provided record.
How did the court rule in Alere Medical v. Health Hero Network (1:07-cv-07145)?
Featured answer: The specific outcomes (dismissals, partial summary judgment, claim construction, injunctions, damages rulings, or judgment) are not provided here, so a ruling-level summary cannot be stated accurately.
Were there injunctions, damages awards, or ongoing relief?
Featured answer: Not determinable from the available material.
Was the case terminated by settlement, dismissal, or judgment?
Featured answer: The disposition mechanism cannot be identified from the available information.
What does 1:07-cv-07145 mean for freedom to operate (FTO) for Health Hero Network and competitors?
Featured answer: Without identifying asserted rights and rulings, the impact on FTO cannot be tied to concrete restrictions (design-around requirements, product labeling changes, licensing obligations, or adjudicated invalidity/non-infringement findings).
Design-around or product repositioning
Featured answer: Not determinable.
Licensing or settlement constraints
Featured answer: Not determinable.
Downstream risk for similar products
Featured answer: Not determinable.
Does the litigation affect FDA commercialization, Orange Book status, or generic/biosimilar entry?
Featured answer: There is no provided linkage between the litigation and a specific FDA-approved product with Orange Book listings or an asserted formulation/product under FDA regulation.
Orange Book listings for any involved drug
Featured answer: Not determinable.
Paragraph IV / 505(b)(2) / 505(j) relevance
Featured answer: Not determinable.
Biosimilar risk
Featured answer: Not determinable.
Which companies and counsel were involved, and what does that imply about leverage and case strategy?
Featured answer: Party names are visible from the request, but counsel identity, law firm roles, and strategy signals from filings are not available in the provided material.
Alere Medical’s likely licensing posture
Featured answer: Not determinable.
Health Hero Network’s likely defense posture
Featured answer: Not determinable.
Key Case Artifacts (What to pull from the docket to complete the analysis)
Featured answer: The case can be analyzed precisely only from docket documents (complaint, amended complaint, answer, claim construction/order documents, motion papers, and the final order/judgment). Those documents are not present in the available record here.
Minimum docket documents needed
- Complaint and any amended complaints
- Answer and affirmative defenses
- Claim construction orders (if patent case)
- Summary judgment orders
- Final judgment or stipulated dismissal/settlement order
- Any injunction order or consent judgment language
Key Takeaways
- The case identifier (1:07-cv-07145) is provided, but the operative pleading content, asserted rights, court rulings, and disposition details are not included in the available material.
- A litigation summary at the resolution-level cannot be produced without patent/trademark/copyright identifiers and docket event specifics, which are not present here.
FAQs
1) What patents or trademarks did Alere Medical assert against Health Hero Network in 1:07-cv-07145?
Not stated in the available record.
2) Did the court issue a claim construction order or Markman decision in 1:07-cv-07145?
Not determinable from the available record.
3) Was 1:07-cv-07145 resolved by settlement or court judgment?
Not determinable from the available record.
4) Does the litigation connect to any specific FDA product or Orange Book listing?
No FDA/Orange Book linkage is provided in the available record.
5) What is the FTO impact of this case for similar medical products?
Cannot be tied to concrete restrictions without identifying asserted rights and outcomes.
References (APA)
- Alere Medical, Inc. v. Health Hero Network, Inc., No. 1:07-cv-07145 (D.N.J.).
More… ↓
